Element Biosciences, Inc., a San Diego, Calif.-based company focused on the development of genetic analysis tools, secured $15m in Series A funding.
The round was led by Foresite Capital and Venrock.
The company intends to use the funds for the development of technologies designed to improve quality and reduce the cost of genomic applications.
Led by Molly He, co-founder and CEO, Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets. The company’s technology will broaden the end user experience through data and workflows to benefit discoveries and diagnosis in healthcare.